CollPlant Biotechnologies (CLGN) Return on Assets (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Return on Assets of 0.03% for Q4 2025, down 49.88% on a QoQ basis from 0.02% in Q3 2025, and little changed year-over-year from 0.03% in Q4 2024.
CollPlant Biotechnologies (CLGN) Return on Assets (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Return on Assets history runs 8 years deep, the most recent figure standing at 0.03% for Q4 2025.
- Quarterly Return on Assets changed 0.0% year-over-year to 0.03% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.03% (changed 0.0% YoY) and the FY2025 annual result came in at 0.03%, down 1.0% from the prior year.
- Return on Assets was 0.03% for Q4 2025 at CollPlant Biotechnologies, down from 0.02% in the prior quarter.
- Across five years, Return on Assets topped out at 0.03% in Q1 2021 and bottomed at 0.05% in Q3 2022.
- A 5-year average of 0.01% and a median of 0.01% in 2023 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2022 — Return on Assets dropped 7 bps — and 2023, when it advanced 4 bps.
- CollPlant Biotechnologies' Return on Assets stood at 0.03% in 2021, then surged by 71 bps to 0.01% in 2022, then tumbled by 41 bps to 0.01% in 2023, then sank by 108 bps to 0.02% in 2024, then decreased by 13 bps to 0.03% in 2025.
- Business Quant data shows CLGN's Return on Assets at 0.03% in Q4 2025, 0.02% in Q3 2025, and 0.02% in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -0.69% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -0.01% |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -0.80% |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 0.00% |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | -0.02% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.05% |
| Jun 30, 2022 | -0.03% |
| Mar 31, 2022 | -0.03% |
| Dec 31, 2021 | -0.03% |
| Sep 30, 2021 | 0.02% |
| Jun 30, 2021 | 0.01% |
| Mar 31, 2021 | 0.03% |
| Dec 31, 2020 | 0.01% |
| Sep 30, 2020 | 0.02% |